Recursion Pharmaceuticals, Inc. (RXRX)
3.45
-0.09
(-2.54%)
USD |
NASDAQ |
Mar 06, 15:57
Recursion Pharmaceuticals Cash from Investing (TTM) : -16.87M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 228.03M |
| Hims & Hers Health, Inc. | -1.025B |
| Novavax, Inc. | -78.27M |
| Geron Corp. | 107.25M |
| XOMA Royalty Corp. | -4.892M |